230 related articles for article (PubMed ID: 22295088)
1. The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.
Lev A; Simon AJ; Bareket M; Bielorai B; Hutt D; Amariglio N; Rechavi G; Somech R
PLoS One; 2012; 7(1):e30494. PubMed ID: 22295088
[TBL] [Abstract][Full Text] [Related]
2. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A
Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000
[TBL] [Abstract][Full Text] [Related]
3. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation.
Dror Y; Gallagher R; Wara DW; Colombe BW; Merino A; Benkerrou M; Cowan MJ
Blood; 1993 Apr; 81(8):2021-30. PubMed ID: 8471764
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Laboratory Factors Affecting the Prognosis of Severe Combined Immunodeficiency.
Ozturk E; Catak MC; Kiykim A; Baser D; Bilgic Eltan S; Yalcin K; Kasap N; Nain E; Bulutoglu A; Akgun G; Can Y; Sefer AP; Babayeva R; Caki-Kilic S; Tezcan Karasu G; Yesilipek A; Ozen A; Karakoc-Aydiner E; Baris S
J Clin Immunol; 2022 Jul; 42(5):1036-1050. PubMed ID: 35451701
[TBL] [Abstract][Full Text] [Related]
5. Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.
Hartnett BJ; Yao D; Suter SE; Ellinwood NM; Henthorn PS; Moore PE; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
Biol Blood Marrow Transplant; 2002; 8(4):188-97. PubMed ID: 12014808
[TBL] [Abstract][Full Text] [Related]
6. The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine deaminase deficiency.
Serana F; Sottini A; Chiarini M; Zanotti C; Ghidini C; Lanfranchi A; Notarangelo LD; Caimi L; Imberti L
J Immunol; 2010 Dec; 185(12):7713-22. PubMed ID: 21057082
[TBL] [Abstract][Full Text] [Related]
7. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
[TBL] [Abstract][Full Text] [Related]
8. CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center.
Gennery AR; Dickinson AM; Brigham K; Barge D; Spickett GP; Curtis A; Spencer V; Jackson A; Cavanagh G; Carter V; Palmer P; Flood TJ; Cant AJ; Abinun M
Cytotherapy; 2001; 3(3):221-32. PubMed ID: 12171729
[TBL] [Abstract][Full Text] [Related]
9. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.
Bertrand Y; Landais P; Friedrich W; Gerritsen B; Morgan G; Fasth A; Cavazzana-Calvo M; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Haddad E; Fischer A
J Pediatr; 1999 Jun; 134(6):740-8. PubMed ID: 10356144
[TBL] [Abstract][Full Text] [Related]
10. Applying T-cell receptor excision circles and immunoglobulin κ-deleting recombination excision circles to patients with primary immunodeficiency diseases.
Lee WI; Huang JL; Lin SJ; Yeh KW; Chen LC; Ou LS; Yao TC; Jaing TH; Shih YF; Tseng TY; Lin YL
Ann Med; 2014 Nov; 46(7):555-65. PubMed ID: 25109505
[TBL] [Abstract][Full Text] [Related]
11. T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation.
Sarzotti M; Patel DD; Li X; Ozaki DA; Cao S; Langdon S; Parrott RE; Coyne K; Buckley RH
J Immunol; 2003 Mar; 170(5):2711-8. PubMed ID: 12594301
[TBL] [Abstract][Full Text] [Related]
12. Long-term T cell immune reconstitution in 2 SCID patients after BMT.
Godthelp BC; van Tol MJ; Vossen JM; van den Elsen PJ
Hum Immunol; 1998 Apr; 59(4):225-38. PubMed ID: 9568798
[TBL] [Abstract][Full Text] [Related]
13. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
[TBL] [Abstract][Full Text] [Related]
14. Newborn Screening for SCID and Other Severe Primary Immunodeficiency in the Polish-German Transborder Area: Experience From the First 14 Months of Collaboration.
Giżewska M; Durda K; Winter T; Ostrowska I; Ołtarzewski M; Klein J; Blankenstein O; Romanowska H; Krzywińska-Zdeb E; Patalan MF; Bartkowiak E; Szczerba N; Seiberling S; Birkenfeld B; Nauck M; von Bernuth H; Meisel C; Bernatowska EA; Walczak M; Pac M
Front Immunol; 2020; 11():1948. PubMed ID: 33178177
[TBL] [Abstract][Full Text] [Related]
15. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
Patel DD; Gooding ME; Parrott RE; Curtis KM; Haynes BF; Buckley RH
N Engl J Med; 2000 May; 342(18):1325-32. PubMed ID: 10793165
[TBL] [Abstract][Full Text] [Related]
16. Treatment of donor T cell-mediated hematopoietic suppression after haploidentical bone marrow transplantation by T cell modulation in a patient with severe combined immunodeficiency.
Dilloo D; Hanenberg H; Schneider EM; Hauch M; Nürnberger W; Zimmer BM; Vöhringer R; Wernet P; Göbel U; Burdach SE
Bone Marrow Transplant; 1992 Jan; 9(1):57-62. PubMed ID: 1531938
[TBL] [Abstract][Full Text] [Related]
17. T cell receptor diversity in severe combined immunodeficiency following HLA-haploidentical bone marrow transplantation.
Knobloch C; Friedrich W
Bone Marrow Transplant; 1991 Nov; 8(5):383-7. PubMed ID: 1768974
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants.
Broers AE; Posthumus-van Sluijs SJ; Spits H; van der Holt B; Löwenberg B; Braakman E; Cornelissen JJ
Blood; 2003 Aug; 102(4):1534-40. PubMed ID: 12714515
[TBL] [Abstract][Full Text] [Related]
19. Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion.
Carbonaro DA; Jin X; Cotoi D; Mi T; Yu XJ; Skelton DC; Dorey F; Kellems RE; Blackburn MR; Kohn DB
Blood; 2008 Jun; 111(12):5745-54. PubMed ID: 18356486
[TBL] [Abstract][Full Text] [Related]
20. Poor T-cell receptor β repertoire diversity early posttransplant for severe combined immunodeficiency predicts failure of immune reconstitution.
Delmonte OM; Castagnoli R; Yu J; Dvorak CC; Cowan MJ; Dávila Saldaña BJ; De Ravin SS; Mamcarz E; Chang CK; Daley SR; Griffith LM; Notarangelo LD; Puck JM
J Allergy Clin Immunol; 2022 Mar; 149(3):1113-1119. PubMed ID: 34384841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
